Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.35 |
| ▸ | RXRB | P28702 | 1/20 | 0.35 |
| ▸ | RXRG | P48443 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 3/20 | 0.34 |
| ▸ | CREBBP | Q92793 | 3/20 | 0.34 |
| ▸ | ACVRL1 | P37023 | 1/20 | 0.32 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.32 |
| ▸ | ATR | Q13535 | 2/20 | 0.31 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30869686 | 0.86 | ATR (0.34) | RXRARXRBRXRGBRD4CREBBP | |
| SCHEMBL30869682 | 0.80 | ATR (0.35) | RXRARXRBRXRGACVRL1ACVR1 | |
| SCHEMBL30869528 | 0.76 | CD274 (0.39) | BRD4CREBBPACVR1ATRCD274 | |
| SCHEMBL32682878 | 0.75 | BRD4 (0.34) | BRD4CREBBPATR | |
| SCHEMBL30869853 | 0.74 | ABL1 (0.36) | — | |
| SCHEMBL30869614 | 0.71 | RXRA (0.34) | RXRARXRBRXRGACVRL1ACVR1 | |
| SCHEMBL30869723 | 0.68 | PRKCQ (0.42) | BRD4 | |
| SCHEMBL30869841 | 0.65 | PDE10A (0.37) | CD274 | |
| SCHEMBL32682876 | 0.65 | KDM1A (0.39) | ATR | |
| SCHEMBL30869445 | 0.64 | GRIA1 (0.43) | ACVR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4583868-A2 | DYNAMIN ACTIVATORS | Walden Biosciences, Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054661-A2 | DYNAMIN ACTIVATORS | WALDEN BIOSCIENCES (US) | 2024-03-14 | — | — | WO | disclosed |